Posted by admin on May 16th, 2022

Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF – Get Rating) and Conformis (NASDAQ:CFMS – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Shandong Weigao Group Medical Polymer has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Comparatively, Conformis has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500.

This table compares Shandong Weigao Group Medical Polymer and Conformis’ net margins, return on equity and return on assets.

51.0% of Conformis shares are held by institutional investors. 3.0% of Conformis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

This table compares Shandong Weigao Group Medical Polymer and Conformis’ gross revenue, earnings per share (EPS) and valuation.

Shandong Weigao Group Medical Polymer has higher revenue and earnings than Conformis.

This is a summary of current ratings and price targets for Shandong Weigao Group Medical Polymer and Conformis, as reported by MarketBeat.

Conformis has a consensus target price of $2.00, indicating a potential upside of 437.20%. Given Conformis’ higher probable upside, analysts plainly believe Conformis is more favorable than Shandong Weigao Group Medical Polymer.

Shandong Weigao Group Medical Polymer beats Conformis on 6 of the 11 factors compared between the two stocks.

Shandong Weigao Group Medical Polymer Company Profile (Get Rating)

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. The company operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. It offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound healing dressings, wound sutures, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. The company also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, it engages in the production and sale of orthopedic products; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemo-dialysis equipment; and type I, type II, and type III medical devices. Further, the company is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; and provision of asset management and enterprise consulting services, as well as logistics and storage services. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. The company also export its products. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

Conformis Company Profile (Get Rating)

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Receive News & Ratings for Shandong Weigao Group Medical Polymer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shandong Weigao Group Medical Polymer and related companies with MarketBeat.com's FREE daily email newsletter.

Cielo (OTCMKTS:CIOXY) vs. Tabula Rasa HealthCare (NASDAQ:TRHC) Head-To-Head Comparison

Head to Head Comparison: Valaris (NYSE:VAL) vs. Seadrill (OTCMKTS:SDRLF)